Seconda Universita Di Napoli
- Address
- lock Available on a paid plan
Hemic and Lymphatic Diseases
At Seconda Universita Di Napoli, clinical research in Hemic and Lymphatic Diseases focuses mainly on acute lymphoblastic leukemia and Langerhans Cell Histiocytosis. The trials are designed to improve survival, reduce relapse, and refine treatment strategies for children and adolescents.
- Testing new treatment approaches for Philadelphia chromosome-positive acute lymphoblastic leukemia
- Evaluating therapy options for pediatric B-ALL and T-ALL based on disease risk and response
- Studying ways to lower reactivation and late effects in Langerhans Cell Histiocytosis
These studies aim to make care more effective and better tailored to young patients with blood-related cancers and immune system disorders.
Neoplasms
Research in Neoplasms at this site includes colon cancer and metastatic gastric adenocarcinoma, with a strong interest in improving cancer control and treatment response. The work includes testing new combinations and comparing treatment effectiveness in gastrointestinal cancers.
- Assessing new approaches for colorectal cancer to strengthen immune-based treatment
- Comparing therapies for HER2-positive gastric cancer and gastro-esophageal junction disease
- Exploring options to improve outcomes in advanced pMMR/MSS tumors
The research reflects a broader effort to improve outcomes for patients with hard-to-treat solid tumors through more targeted and innovative therapies.
Hormonal Diseases
Clinical trials in Hormonal diseases are centered on growth disorders in children, including those born small for gestational age and children with Turner syndrome, Noonan syndrome, or idiopathic short stature. The goal is to evaluate treatments that may support healthier growth over time.
- Comparing growth treatment options for children with short stature
- Studying treatment effectiveness across SGA, Turner syndrome, Noonan syndrome, and idiopathic short stature
- Focusing on improved growth outcomes and practical long-term care
This area highlights pediatric endocrinology research aimed at helping children reach better growth potential through more convenient and effective therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 41 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 41 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Seconda Universita Di Napoli
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Comparative Study of Somapacitan and Somatropin in Pediatric Patients with Short Stature Due to SGA, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
lock Showing 1 of 41 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 3 | Unknown | 2017-10-02 | 2024-10-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.